Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 26 resultados

ENDONANO: Quantitative detection of bacterial endotoxin by novel nanotechnological approaches ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020: H2020-MSCA-ITN-2018 ENDONANO (Quantitative detection of bacterial endotoxin by novel nanotechnological approaches) addresses a key regulatory and safety issue,...
2018-07-19 - 2023-06-30 | Financiado

HIPGEN: Placenta expanded adherent stromal cells PLX PAD as an innovative therapy for improving recovery a... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020: H2020-SC1-2016-2017 Aim of the HIPGEN project is to develop the first cell therapy to improve functional recovery following hip fracture arthroplasty. Hip fract...
2017-11-21 - 2022-09-30 | Financiado

LIVERHOPE: SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020: H2020-SC1-2016-2017 Liver cirrhosis is a very common chronic disease and one of the leading causes of death in European. Moreover, cirrhosis has a marked impact...
2016-12-09 - 2023-02-28 | Financiado

PACE: A multicenter phase IIb study using HLA unmatched allogeneic placenta derived stromal cells PLX PAD... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020: H2020-SC1-2016-2017 PACE aims to transform the treatment of patients suffering from critical limb ischemia (CLI), a disease with high medical need, because of l...
2016-12-01 - 2021-12-31 | Financiado

MarPipe: Improving the flow in the pipeline of the next generation of marine biodiscovery scientists ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020: H2020-MSCA-ITN-2016 MarPipe is a consortium of 11 partners (IBP-CNR, SZN, UiT, UNIABDN, GEOMAR, KULeuven, UCC, eCOAST, MEDINA, MicroDish, Italbiotec) based in 8...
2016-08-29 - 2021-04-30 | Financiado

HEP-CAR: Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co morbidities. ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020: H2020-PHC-2014-2015 Hepatocellular carcinoma (HCC) is the most common liver malignancy, with an estimated 750,000 new cases and 695,000 deaths per year, rating...
2015-12-02 - 2019-12-31 | Financiado

GLYCOVAX: A training network for the rational design of the next generation of well defined glycoconjugate vac... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020: H2020-MSCA-ITN-2015 GLYCOVAX is a network for the education of promising young scientists who will learn how to rationally design a next generation of well-defi...
2015-08-11 - 2019-10-31 | Financiado

PANDORA: Probing safety of nano objects by defining immune responses of environmental organisms ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020: H2020-MSCA-ITN-2015 PANDORA (Probing safety of nano-objects by defining immune responses of environmental organisms) shall assess the global impact of engineere...
2015-08-10 - 2019-12-31 | Financiado

ImmunoAgeing: An integrated approach to dissect determinants risk factors and pathways of ageing of the immune sy... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un H2020: H2020-PHC-2014-2015 Age-related changes in the immune system, also known as ‘immunosenescence’, have a huge detrimental impact on the health of our ageing popul...
2015-04-07 - 2019-04-30 | Financiado

ABIRISK: Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the ri... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP6: The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique pane...
2012-03-01 - 2018-02-28 | Financiado

ABIRISK: Anti Biopharmaceutical Immunization Prediction and analysis of clinical relevance to minimize the ri... ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7: The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique pane...
Financiado

Athero-Flux: Targeting novel lipid pathways for treatment of cardiovascular disease ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7: Lipid lowering has significantly reduced cardiovascular disease (CVD) mortality in EU. However, the aim to abolish CVD in EU is far from ach...
Financiado

Athero-B-Cell: Targeting and exploiting B cell functions for treatment in cardiovascular disease ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7: Cardiovascular disease (CVD) mortality and morbidity is predicted to increase in Europe and worldwide in the next decades due to aging and t...
Financiado

ADITEC: Advanced Immunization Technologies ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7: Vaccines so far have been developed mostly by following an empiric approach. To prevent and possibly cure unresolved and emerging infectious...
Financiado

HERACLES: Human cystic Echinococcosis ReseArch in CentraL and Eastern Societies ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7: Human cystic echinococcosis (CE), one of the most widespread helminthic zoonoses, is a chronic disease caused by infection with the larval s...
Financiado

PANACREAS: Integrating chemical approaches to treat pancreatic cancer making new leads for a cure ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7: Pancreatic ductal adenocarcinoma (PDAC) causes 34000 deaths in the EU every year. Conventional cancer treatments have close to no impact on...
Financiado

TIMER: TargetIng novel MEchanisms of Resolution in inflammation ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7: Resolution of inflammation is a key determinant of pathology, and an active process which involves diverse pathways and molecules. The gener...
Financiado

BioCog: Biomarker Development for Postoperative Cognitive Impairment in the Elderly ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7: Postoperative delirium (POD) is characterized by the progressive deterioration of sensory/cognitive function after surgery with incidences o...
Financiado

STAR-T REK: Set up and comparison of multiple stem cell approaches for kidney repair ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7: With the increasing rate of end-stage renal failure and limited alternatives for its treatment, potential regenerative approaches for kidney...
Financiado

PathCO: Pathogen COinfection HIV Tuberculosis Malaria and Hepatitis C virus ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRLU participó en un FP7: Acquired immune deficiency (AIDS), tuberculosis (TB) and malaria are the primary infectious diseases causing death world wide. In addition t...
Financiado

ALTA SRLU